pipette
ESEspañol

Mitochondrial NAD+ import gates neuronal resilience to active SARM1

L. Barbar, A. Bhat, S. J. Chen, A. Strickland, S. Schurr, S. Sundali, H. Kim, Y. Sasaki, A. J. Bloom, J. Milbrandt, A. DiAntonio

PreprintReal-world use

In the authors' words

SARM1 is an inducible NADase that executes pathological axon degeneration, but how NAD+ destruction causes neuronal failure remains unclear. Because SARM1 is predicted to act outside the mitochondrial matrix, cytosolic NAD+ loss has been viewed as the critical lethal lesion. We show that SARM1 activation rapidly depletes cytosolic and mitochondrial NAD+ and collapses ATP in both compartments, revealing early, coupled metabolic failure. Enhancing mitochondrial NAD+ import through SLC25A51, the mitochondrial NAD+ transporter, preserves mitochondrial NAD+, maintains mitochondrial function, and delays axon degeneration and neuronal death despite ongoing SARM1 activity. Unexpectedly, SLC25A51 restores cytosolic NAD+-dependent metabolism, reversing a glycolytic block and increasing NAD+ synthesis during stress. Glycolytic inhibition attenuates protection, identifying cytosolic metabolic recovery as an important component of neuronal resilience. AAV-SLC25A51 improves function in a chronic SARM1-dependent neuropathy model. Thus, mitochondrial NAD+ import gates SARM1-driven degeneration by limiting coupled mitochondrial-cytosolic metabolic failure, presenting a downstream intervention point for axon preservation.

Main resultThe abstract does not state a limitation.

Appeared: Monday, October 12. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.05.756890